1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Finland >
  5. Shenzhen Mindray Bio-Medical Electronics Acquires HyTest

M&A Deal Summary

Shenzhen Mindray Bio-Medical Electronics Acquires HyTest

On May 16, 2021, Shenzhen Mindray Bio-Medical Electronics acquired life science company HyTest from Summa Equity for 545M EUR

Acquisition Highlights
  • This is Shenzhen Mindray Bio-Medical Electronics’ 2nd transaction in the Life Science sector.
  • This is Shenzhen Mindray Bio-Medical Electronics’ largest (disclosed) transaction.
  • This is Shenzhen Mindray Bio-Medical Electronics’ 1st transaction in Finland.

M&A Deal Summary
Date 2021-05-16
Target HyTest
Sector Life Science
Buyer(s) Shenzhen Mindray Bio-Medical Electronics
Sellers(s) Summa Equity
Deal Type Add-on Acquisition
Deal Value 545M EUR
Advisor(s) William Blair (Financial)
Avance Attorney (Legal)

Target

HyTest

Turku, Finland
HyTest produces antibodies and antigens for the IVD industry for use as key components of various laboratory assays and kits. HyTest’s customer base includes a large number of companies that supply IVD equipment, including many of the global leaders in the IVD market. The company is active across the globe, including US, Asia and Europe. HyTest was founded in 1994 and is based in Turku, Finland.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Shenzhen Mindray Bio-Medical Electronics

Shenzhen, China
Category Company
Founded 1991
Sector Healthcare Services
Employees21,667
Revenue 36.7B CNY (2024)
DESCRIPTION

Shenzhen Mindray Bio-Medical Electronics is a developer, manufacturer and marketer of medical devices. Shenzhen Mindray Bio-Medical Electronics was founded in 1991 and is based in Shenzhen, China.

DEAL STATS #
Overall 11 of 11
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 4 of 4
Country: Finland M&A 1 of 1
Year: 2021 M&A 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-17 Wuhan Dragonbio Surgical Implant Co.

Wuhan, China

Wuhan Dragonbio Surgical Implant Co., Ltd. ("Dragonbio"), is a domestic medical orthopedic products provider that specializes in trauma, spine, joint and other surgical products.

Buy -

Seller(S) 1

SELLER

Summa Equity

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2016
PE ASSETS 14.0B SEK
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Summa Equity is a private equity firm that looks to invest €10 to €50 million per transaction and pursues growing companies with significant business relations in the Nordic region. Summa Equity was formed in 2016 and is headquartered in Stockholm, Sweden.

DEAL STATS #
Overall 5 of 8
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 3
Country: Finland M&A 1 of 1
Year: 2021 M&A 4 of 5
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-06 Holdbart

Oslo, Norway

Holdbart is an online store sells groceries through payment solution Netaxept provided by NETS. Holdbart was founded in 2015 and is based in Oslo, Norway.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-30 myneva

Essen, Germany

myneva is an European software providers for the social care sector. myneva helps to digitize workflows and supports the increasing convergence of client needs across the elderly, disabled, social and youth care segments. myneva was founded in 2017 and is based in Hamburg, Germany.

Buy -
Mergr

Solution for

Product

Company

Legal